FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2024825037> ?p ?o ?g. }

• W2024825037 endingPage "73" @default.
• W2024825037 startingPage "62" @default.
• W2024825037 abstract "Numerous studies have suggested that the central alpha2-adrenergic receptor system may exert an important role in some types of human anxiety. The anxiolytic-like activity and potential side effect-like activities of the novel and purported alpha2-adrenergic compound TDIQ (5,6,7,8-1,3-dioxolo[4,5-g]isoquinoline) were compared to those of the anxiolytic drugs diazepam and buspirone, and the nonselective alpha2-adrenergic agent clonidine. Anxiolytic-like behavior was assessed in an object (marble)-burying assay, a selective test for the evaluation of known anxiolytics and identification of putative antianxiety compounds, that used mice housed either alone or in groups (5/cage). The rodents' antianxiety-like effect was defined as dose-related increases in the number of marbles that remained uncovered in their bedding material without concomitant disruption of their motor activities. Rotarod and inclined screen procedures were employed as potential indicators of side effects. An additional test monitored the heart rate (HR) and blood pressure (BP) of mice after the intravenous (IV) administration of doses of TDIQ. The reference compounds inhibited marble-burying behavior in a dose-related manner and produced various degrees of impairment in the side effect tests. TDIQ also inhibited object burying and displayed a wide separation between doses that produced anxiolytic-like activity and doses that produced some, if any, disruption of coordinated movement and/or motor activity. Moreover, the IV administration of TDIQ, up to 10 mg/kg, produced negligible effects on the HR and BP of mice. TDIQ could be a lead candidate for a new type of structural compound in the treatment of certain forms of anxiety." @default.
• W2024825037 created "2016-06-24" @default.
• W2024825037 creator A5009073724 @default.
• W2024825037 creator A5011571754 @default.
• W2024825037 creator A5020855452 @default.
• W2024825037 creator A5064675740 @default.
• W2024825037 date "2006-05-01" @default.
• W2024825037 modified "2023-10-14" @default.
• W2024825037 title "TDIQ (5,6,7,8-tetrahydro-1,3-dioxolo[4,5-g]isoquinoline) exhibits anxiolytic-like activity in a marble-burying assay in mice" @default.
• W2024825037 cites W101375041 @default.
• W2024825037 cites W1593645241 @default.
• W2024825037 cites W1901890248 @default.
• W2024825037 cites W1965762855 @default.
• W2024825037 cites W1967566231 @default.
• W2024825037 cites W1970093256 @default.
• W2024825037 cites W1971721277 @default.
• W2024825037 cites W1977407356 @default.
• W2024825037 cites W1992636777 @default.
• W2024825037 cites W2006490359 @default.
• W2024825037 cites W2022483716 @default.
• W2024825037 cites W2023564789 @default.
• W2024825037 cites W2025593500 @default.
• W2024825037 cites W2030191470 @default.
• W2024825037 cites W2030638522 @default.
• W2024825037 cites W2032842245 @default.
• W2024825037 cites W2033981250 @default.
• W2024825037 cites W2036611494 @default.
• W2024825037 cites W204404340 @default.
• W2024825037 cites W2047319932 @default.
• W2024825037 cites W2051226969 @default.
• W2024825037 cites W2053714798 @default.
• W2024825037 cites W2053872340 @default.
• W2024825037 cites W2056249673 @default.
• W2024825037 cites W2057355532 @default.
• W2024825037 cites W2058137137 @default.
• W2024825037 cites W2065209030 @default.
• W2024825037 cites W2077847254 @default.
• W2024825037 cites W2091311469 @default.
• W2024825037 cites W2103069362 @default.
• W2024825037 cites W2129928127 @default.
• W2024825037 cites W2166380935 @default.
• W2024825037 cites W2170897385 @default.
• W2024825037 cites W2182242129 @default.
• W2024825037 cites W2261298988 @default.
• W2024825037 doi "https://doi.org/10.1016/j.pbb.2006.04.006" @default.
• W2024825037 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16750844" @default.
• W2024825037 hasPublicationYear "2006" @default.
• W2024825037 type Work @default.
• W2024825037 sameAs 2024825037 @default.
• W2024825037 citedByCount "21" @default.
• W2024825037 countsByYear W20248250372013 @default.
• W2024825037 countsByYear W20248250372014 @default.
• W2024825037 countsByYear W20248250372017 @default.
• W2024825037 countsByYear W20248250372018 @default.
• W2024825037 countsByYear W20248250372020 @default.
• W2024825037 countsByYear W20248250372023 @default.
• W2024825037 crossrefType "journal-article" @default.
• W2024825037 hasAuthorship W2024825037A5009073724 @default.
• W2024825037 hasAuthorship W2024825037A5011571754 @default.
• W2024825037 hasAuthorship W2024825037A5020855452 @default.
• W2024825037 hasAuthorship W2024825037A5064675740 @default.
• W2024825037 hasConcept C118552586 @default.
• W2024825037 hasConcept C134018914 @default.
• W2024825037 hasConcept C15744967 @default.
• W2024825037 hasConcept C170493617 @default.
• W2024825037 hasConcept C173586616 @default.
• W2024825037 hasConcept C185592680 @default.
• W2024825037 hasConcept C2776175493 @default.
• W2024825037 hasConcept C2776923262 @default.
• W2024825037 hasConcept C2777287423 @default.
• W2024825037 hasConcept C2777765862 @default.
• W2024825037 hasConcept C2778399450 @default.
• W2024825037 hasConcept C2778938600 @default.
• W2024825037 hasConcept C40465926 @default.
• W2024825037 hasConcept C55493867 @default.
• W2024825037 hasConcept C558461103 @default.
• W2024825037 hasConcept C71240020 @default.
• W2024825037 hasConcept C71924100 @default.
• W2024825037 hasConcept C98274493 @default.
• W2024825037 hasConceptScore W2024825037C118552586 @default.
• W2024825037 hasConceptScore W2024825037C134018914 @default.
• W2024825037 hasConceptScore W2024825037C15744967 @default.
• W2024825037 hasConceptScore W2024825037C170493617 @default.
• W2024825037 hasConceptScore W2024825037C173586616 @default.
• W2024825037 hasConceptScore W2024825037C185592680 @default.
• W2024825037 hasConceptScore W2024825037C2776175493 @default.
• W2024825037 hasConceptScore W2024825037C2776923262 @default.
• W2024825037 hasConceptScore W2024825037C2777287423 @default.
• W2024825037 hasConceptScore W2024825037C2777765862 @default.
• W2024825037 hasConceptScore W2024825037C2778399450 @default.
• W2024825037 hasConceptScore W2024825037C2778938600 @default.
• W2024825037 hasConceptScore W2024825037C40465926 @default.
• W2024825037 hasConceptScore W2024825037C55493867 @default.
• W2024825037 hasConceptScore W2024825037C558461103 @default.
• W2024825037 hasConceptScore W2024825037C71240020 @default.
• W2024825037 hasConceptScore W2024825037C71924100 @default.
• W2024825037 hasConceptScore W2024825037C98274493 @default.
• W2024825037 hasIssue "1" @default.

• next